Trending

EASD

The ‘game changers’ in diabetes: Novo and Lilly battle it out

The ‘game changers’ in diabetes: Novo and Lilly battle it out

Two diabetes drugs, Lilly and Boehringer Ingelheim’s (BI) Jardiance and Novo Nordisk’s Victoza, have shown they can go

X

The ‘game changers’ in diabetes: Novo and Lilly battle it out

https://pharmaphorum.com/views-and-analysis/diabetes-drugs-prevent-heart-attacks-strokes-novo-lilly-battle/

AZ success with novel diabetes combo

AZ success with novel diabetes combo

First company to put GLP-1 together with SGLT2 class

X

AZ success with novel diabetes combo

https://pharmaphorum.com/news/az-success-novel-diabetes-combo/

Sanofi and Novo battle it out with diabetes combinations

Sanofi and Novo battle it out with diabetes combinations

New data presented at EASD in Munich

X

Sanofi and Novo battle it out with diabetes combinations

https://pharmaphorum.com/news/sanofi-novo-battle-diabetes-combinations/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com